Tag: abbreviated new drug application

April 4, 2019

Teligent Receives FDA Approval of Fluocinonide Cream USP, 0.1 Percent

Teligent (NASDAQ:TLGT) has announced it has received approval for its abbreviated new drug application from the US Food and Drug...
November 27, 2018

Akorn Receives Product Approval

Akorn (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, announced that it received a new Abbreviated New Drug Application (ANDA) approval...
October 29, 2018

Akorn Receives Product Approval

Akorn (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new Abbreviated New...